Insider Purchase: DaVita Director Acquires 369 Shares (Form 4)
Rhea-AI Filing Summary
DaVita Inc. director Barbara J. Desoer, through an attorney-in-fact, reported acquiring 369 shares of DaVita common stock on 08/15/2025 at no cash price indicated on the form and holds 369 shares directly following the transaction. The filing shows she also has indirect beneficial ownership of 12,659 shares through the Marc J. Desoer and Barbara J. Desoer 1998 Trust dated September 7, 1998. The Form 4 was signed by Stephanie N. Berberich as attorney-in-fact on 08/19/2025.
Positive
- None.
Negative
- None.
Insights
TL;DR: Small insider acquisition by a director; immaterial to company valuation but shows insider buying.
The reported purchase of 369 shares by Director Barbara J. Desoer is a routine insider transaction disclosed on Form 4. Given the reported size (369 shares) relative to a public company of DaVita's scale, this trade is unlikely to be material to the companys capitalization or operations. The filing also confirms existing indirect ownership of 12,659 shares via a family trust, clarifying the reporting persons aggregate holdings. No derivative transactions or additional compensatory awards are reported.
TL;DR: Governance disclosure is complete for the transaction; filing follows Section 16 reporting protocols.
The Form 4 discloses the directors purchase and the trust-based indirect ownership, meeting Section 16(a) requirements. The filing was executed by an attorney-in-fact and includes the trustee-related indirect ownership attribution. There are no amendments, derivative instruments, or other unusual features reported that would raise governance concerns.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 369 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
AI-generated analysis. How Rhea-AI works. Not financial advice.